3Zamani M, Spaepen M, Sghar SS, et al.Linkage and association of HLA class Ⅱ genes with vitiligo in a Dutch population. Br J Dermatol 2001; 145:90 - 94.
4Buc M, Fazekasova H, Cechova E, et al.Occurrence rates of HLA- DRB1, HLADQB1, and HLA- DPB1 alleles in patients suffering from vitiligo. Eur J Dermatol 1998;8:13 - 15.
5Tripathi PK, Fianders DJ, Young TL, et al.Microphthalmia-associated transcription factor(MITF) locus lacks linkage to human vitiligo or osteoptrosis: an evaluation. Pignent Cell Res 1999;12:187- 192.
6Alkhateeb A, Stetker GL, Old W, et al.Mapping of an autoimmunity susceptibility locus (AISL) to chromosome 1p31.3 - p32.3.Hum Mol Genet 2002;11:661-667.
7Xie Z, Chen D, Jiao D, et al. Vitiligo antibodies are not directed to tyrosinase. Arch Dermatol 1999; 135:417 - 422.
8Palermo B, Campanelli R, Garbelli S, et al.Specific cytotoxic T lymphocyte responses against Melan - A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocopatibility complex/peptide tetramers: the role of cellular immunity in the etiopathngegesis of vitiligo. J Invest Dermatol 2001; 117: 326 -332.
9Mahmoud F, Abul H, al - Saleh Q, et al.Peripheral T- cell activation in non - segmental vitiligo. J Dermatol 1998; 25:637 -640.
10Mahmoud F, Abul H, Haines D, et al. Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+ CD45RO+ and CD4+ CD25+ of Thelper cells in non- segmental vitiligo. J Dermatol 2002;29:68 - 73.
